Gilla Kaplan
Director, CELGENE CORP /DE/.
Companies
- Tyra Biosciences, Inc.Board member Sep 14, 2021 to now1
- Avalo Therapeutics, Inc.Board member Oct 13, 2020 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Tyra Biosciences, Inc. TYRA28,231 shares3$539.2K at $19.10Mar 26, 2026
- Avalo Therapeutics, Inc. AVTX6,333 shares4$71.4K at $11.27Mar 28, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 28, 2026Exercised options 3,166 shares of Avalo Therapeutics, Inc.4
- Mar 26, 2026Returned to company 53,172 shares at $37.75 of Tyra Biosciences, Inc.3
- Mar 26, 2026Exercised options 53,172 shares at $2.25 of Tyra Biosciences, Inc.3
- Mar 25, 2026Sold 14,295 shares at $36.97 of Tyra Biosciences, Inc.3
- Mar 25, 2026Exercised options 14,295 shares at $2.25 of Tyra Biosciences, Inc.3
- Jun 18, 2025Sold 9,568 shares at $9.78 of Tyra Biosciences, Inc.5
- Jun 17, 2025Sold 10 shares at $10.35 of Tyra Biosciences, Inc.5
- Jun 16, 2025Sold 6,814 shares at $10.38 of Tyra Biosciences, Inc.6
- Jun 13, 2025Sold 15,000 shares at $10.31 of Tyra Biosciences, Inc.6
- Jun 12, 2025Sold 30,000 shares at $10.31 of Tyra Biosciences, Inc.6
- Mar 28, 2025Exercised options 3,167 shares of Avalo Therapeutics, Inc.7
- Jun 13, 2024Exercised options 61,392 shares at $0.61 of Tyra Biosciences, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARTyra Biosciences, Inc., Board member
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Jun 20, 2025
- 6SEC EDGARForm 4 filed Jun 16, 2025
- 7SEC EDGARForm 4 filed Apr 1, 2025
- 8SEC EDGARForm 4 filed Jun 18, 2024